comparemela.com

Latest Breaking News On - Drugs control general - Page 3 : comparemela.com

Odisha floats e-tender to buy 3 80 crore doses of Covid vaccines | Bhubaneswar News

Image used for representational purpose only BHUBANESWAR: Odisha on Friday floated an e-tender to buy 3.80 crore Covid vaccine within 120 days from the date of signing the agreement. The tender by state PSU Odisha State Medical Corporation Limited (OSMCL) has sought bidders for supply of vaccines either by manufacturers in India or Indian importers in case of foreign vaccines approved by Drugs Control General of India. The tender said the bidder has to supply 75 lakh doses within 30 days, 2.25 crore within 60 days, 3.75 crore within 90 days and the rest within 120 days. The OSMCL would issue separate purchase order for each of the above four phases of supply.

COVID-19 vaccines: Is foreign good for India

COVID-19 vaccines: Is foreign good for India
downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.

Confused about COVID vaccines in India? This is for you

Confused about COVID vaccines in India? This is for you Confused about COVID vaccines in India? This is for you Last Updated: Wed, Apr 14th, 2021, 07:54:32hrs New Delhi: The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about: Manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology, it uses an inactivated virus. It is developed by chemically treating novel coronavirus samples to make them incapable of reproduction.

COVID-19 Vaccine Update: Many nations pause Johnson & Johnson s vaccine over rare blood clots, India plans rollout

COVID-19 Vaccine Update: Many nations pause Johnson & Johnson s vaccine over rare blood clots, India plans rollout Somya Lohia © Somya Lohia COVID-19 Vaccine Update: Many nations pause Johnson & Johnson s vaccine over rare blood clots, India plans rollout The use of Johnson & Johnson s COVID-19 vaccine has been paused in the United States for at least a few days on the recommendation of the US Food and Drug Administration (USFDA) following the development of rare blood clots in few recipients after receiving the shot. The US recommended that states pause giving the J&J vaccine on April 13 while authorities examine six reports of the unusual clots, including a death, out of more than 6.8 million Americans given the one-dose vaccination so far.

Confused about COVID vaccines in India? This is for you

Confused about COVID vaccines in India? This is for you
sify.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sify.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.